Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) Assets Average (2024 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Assets Average for 2 consecutive years, with $139.9 million as the latest value for Q4 2025.

  • Quarterly Assets Average fell 35.7% to $139.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $139.9 million through Dec 2025, down 35.7% year-over-year, with the annual reading at $170.3 million for FY2025, 8.21% up from the prior year.
  • Assets Average for Q4 2025 was $139.9 million at Artiva Biotherapeutics, down from $159.1 million in the prior quarter.
  • The five-year high for Assets Average was $217.6 million in Q4 2024, with the low at $139.9 million in Q4 2025.